Page 722 - 16Neonatal Jaundice_compressed

Neonatal jaundice

176. Tontisirin K, Tejavej A, Siripoonya P et al. Effect of phototherapy on nutrients utilization in newborn infants with jaundice. Journal
of the Medical Association of Thailand 1989; 72 Suppl 1:177-82.
177. Speck WT and Rosenkranz HS. Phototherapy for neonatal hyperbilirubinemia--a potential environmental health hazard to
newborn infants: a review. Environmental Mutagenesis 1979; 1:(4)321-36.
178. Tatli MM, Minnet C, Kocyigit A et al. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates.
Mutation Research - Genetic Toxicology and Environmental Mutagenesis 2008; 654:(1)93-Genetic.
179. Aycicek A, Kocyigit A, Erel O et al. Phototherapy causes DNA damage in peripheral mononuclear leukocytes in term infants.
Jornal de Pediatria 2008; 84:(2)141-6.
180. Berg P and Lindelof B. Is phototherapy in neonates a risk factor for malignant melanoma development? Archives of Pediatrics and
Adolescent Medicine 1997; 151:(12)1185-7.
181. Mahe E, Beauchet A, Aegerter P et al. Neonatal Blue-Light Phototherapy Does Not Increase Nevus Count in 9-Year-Old Children.
Pediatrics 2009; 123:(5)e896-e900.
182. Matichard E, Le HA, Sanders A et al. Effect of neonatal phototherapy on melanocytic nevus count in children. Archives of
Dermatology 2006; 142:(12)1599-604.
183. Turan O, Ergenekon E, Koc E et al. Impact of phototherapy on vasoactive mediators: NO and VEGF in the newborn. Journal of
Perinatal Medicine 2004; 32:(4)359-64.
184. Rosenfeld W, Sadhev S, Brunot V et al. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants:
prevention with chest shielding. Pediatrics 1986; 78:(1)10-4.
185. Wananukul S and Praisuwanna P. Transepidermal water loss during conventional phototherapy in nonhemolytic
hyperbilirubinemia term infants. Journal of the Medical Association of Thailand 2001; 84 Suppl 1:S46-S50.
186. Maayan-Metzger A, Yosipovitch G, Hadad E et al. Transepidermal water loss and skin hydration in preterm infants during
phototherapy. American Journal of Perinatology 2001; 18:(7)393-6.
187. Grunhagen DJ, De B, De B et al. Transepidermal water loss during halogen spotlight phototherapy in preterm infants. Pediatric
Research 2002; 51:(3)402-5.
188. Wananukul S and Praisuwanna P. Clear topical ointment decreases transepidermal water loss in jaundiced preterm infants
receiving phototherapy. Journal of the Medical Association of Thailand 2002; 85:(1)102-6.
189. Weissman A, Berkowitz E, Smolkin T et al. Effect of phototherapy on neonatal heart rate variability and complexity. Neonatology
2009; 95:(1)41-6.
190. Djokomuljanto S, Quah BS, Surini Y et al. Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white
reflecting curtains. Archives of Disease in Childhood Fetal and Neonatal Edition 2006; 91:(6)F439-F442.
191. Eggert P, Stick C, and Swalve S. On the efficacy of various irradiation regimens in phototherapy of neonatal hyperbilirubinaemia.
European Journal of Pediatrics 1988; 147:(5)525-8.
192. Sivanandan S, Chawla D, Misra S et al. Effect of sling application on efficacy of phototherapy in healthy term neonates with
nonhemolytic jaundice: a randomized conrolled trial. Indian Pediatrics 2009; 46:(1)23-8.
193. Wishingrad L, Cornblath M, Takakuwa T et al. STUDIES OF NON-HEMOLYTIC HYPERBILIRUBINEMIA IN PREMATURE
INFANTS: I. Prospective Randomized Selection for Exchange Transfusion with Observations on the Levels of Serum Bilirubin with
and without Exchange Transfusion and Neurologic Evaluations One Year after Birth. Pediatrics 1965; 36:(2)162-72.
194. Mollison PL and Walker W. Controlled trials of the treatment of haemolytic disease of the newborn. Lancet 1952; 1:(6705)429-33.
195. Armitage P and Mollison PL. Further analysis of controlled trials of treatment of haemolytic disease of the newborn. Journal of
Obstetrics and Gynaecology of the British Empire 1953; 60:(5)605-20.
196. Amato M, Blumberg A, Hermann U, Jr. et al. Effectiveness of single versus double volume exchange transfusion in newborn
infants with AB0 hemolytic disease. Helvetica Paediatrica Acta 1988; 43:(3)177-86.
197. Tan KL. Comparison of the effectiveness of phototherapy and exchange transfusion in the management of nonhemolytic neonatal
hyperbilirubinemia. Journal of Pediatrics 1975; 87:(4)609-12.
198. Chan G and Schiff D. Variance in albumin loading in exchange transfusions. Journal of Pediatrics 1976; 88:(4 Pt. 1)609-13.
199. Grajwer LA, Pildes RS, Zarif M et al. Exchange transfusion in the neonate: a controlled study using frozen-stored erythrocytes
resuspended in plasma. American Journal of Clinical Pathology 1976; 66:(1)117-21.
200. Cockington RA. A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. Journal of Pediatrics
1979; 95:(2)281-5.
201. Locham KK, Kaur K, Tandon R et al. Exchange blood transfusion in neonatal hyperbilirubinemia-role of calcium. Indian Pediatrics
2002; 39:(7)657-9.
202. Ahmed SM, Charoo BA, Iqbal Q et al. Exchange transfusion through peripheral route. Jk Practitioner 2005; 12:(3)118-20.
203. Patra K, Storfer-Isser A, Siner B et al. Adverse events associated with neonatal exchange transfusion in the 1990s. Journal of
Pediatrics 2004; 144:(5)626-31.
204. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997; 99:(5)E7.
205. Voto LS, Sexer H, Ferreiro G et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.
Journal of Perinatal Medicine 1995; 23:(6)443-51.
206. Miqdad AM, Abdelbasit OB, Shaheed MM et al. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia
in ABO hemolytic disease of the newborn. Journal of Maternal-Fetal and Neonatal Medicine 2004; 16:(3)163-Fetal.
207. Rubo J, Albrecht K, Lasch P et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic
disease. Journal of Pediatrics 1992; 121:(1)93-7.
208. Dagoglu T, Ovali F, Samanci N et al. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. Journal of
International Medical Research 1995; 23:(4)264-71.
209. Nasseri F, Mamouri GA, and Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi
Medical Journal 2006; 27:(12)1827-30.
210. Polacek K. Die fruhzeitige Indikationstellung zur Austausch-transfusion bei hamolytischen Neugeborenerkrankungen. Monatsschr
Kinderheilkd 1963; 111:6-10.
211. Polacek K. Das universale Diagramm zur Behandlung der Hyperbilirubinamie der Neugerborenen. Padiatrische Praxis 1984; 29:1-
3.

516